A new FDA-approved low-vibration belt, Osteoboost, is offering a drug-free intervention for osteopenia, a condition characterized by low bone density. Developed by Bone Health Technologies, the belt applies 30 hertz of oscillations per second to stimulate bone cells, mimicking the effects of weight-bearing exercise. Clinical trials showed an average 85% reduction in bone loss among study participants.
The technology behind Osteoboost originates from NASA research on counteracting bone loss in astronauts exposed to zero gravity. By stimulating osteocytes, the belt encourages the formation of new bone matter while recycling old cells. This innovation provides a convenient and effective solution for individuals at risk of osteoporosis, particularly postmenopausal women.
With osteoporosis affecting millions worldwide, Osteoboost represents a significant advancement in bone health management. Researchers anticipate that this wearable device will become a widely adopted tool for preventing fractures and maintaining skeletal strength.
Product Page: Osteobooth Precision Vibration Therapy
Journal Abstract from JBMR Plus: Benefits of Targeted Vibration for Bone Strength and Bone Density in Postmenopausal Women with Osteopenia: A Randomized, Sham-Controlled Trial
